Form D Explorer

Form C-U — Eleison Pharmaceuticals Inc

0001665160-25-000687 · filed 2025-04-16 · via StartEngine Primary, LLC

Offering

Target: $124,000
Maximum: $1,235,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: Eleison Pharmaceuticals Inc
CIK: 1880047
Entity: Corporation
Jurisdiction: DE
Address: 100 OVERLOOK CENTER, 2ND FLOOR
PRINCETON, NJ 08540
Phone: —

Most recent fiscal year financials

Total assets

$729,464

Cash

—

Short-term debt

$3,326,969

Long-term debt

$2,470,118

Revenues

—

COGS

—

Taxes paid

—

Net income

$-2,551,149

View original on SEC EDGAR.